General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Siemens(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Vectura(SIGNIFICANT), Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Agepha(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), New Amsterdam(MODEST), Genentech, Inc(SIGNIFICANT), Idorsia(SIGNIFICANT), Eli Lilly and Company(MODEST) RESEARCH/RESEARCH GRANTS: Bayer Healthcare Pharmaceuticals(NONE), Novo Nordisk Inc.(NONE)
